Midweek cup action continues across Europe, headlined by the first round of league phase fixtures in the UEFA Europa League on Wednesday and Thursday. I'm Pardeep Cattry with the latest in the middle ...
Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome
PLYMOUTH MEETING, Pa., September 24, 2025--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the ...
The Andhra Pradesh State Council of Higher Education (APSCHE) has released the AP EAMCET 2025 phase 3 and final seat allotment results at eapcet-sche.aptonline.in. Candidates must download their ...
The self joining and reporting at allotted colleges will be carried out on or before September 23, 2025, and classwork will commence from September 20, 2025. AP EAMCET 2025: How to check seat ...
CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...
AI-generated edits have become a huge craze online, with each new prompt sparking its own viral moment. Before the much-loved saree trend filled feeds with vintage Bollywood-style portraits, another ...
Sept 11 (Reuters) - Microsoft (MSFT.O), opens new tab and OpenAI said on Thursday they have signed a non-binding deal for new relationship terms that would allow OpenAI to proceed to restructure ...
Frustrated by poor internet connectivity cutting off your favorite music mid-stream? You're not alone. With over 2.7 billion YouTube (News - Alert) users consuming content daily, the demand for ...
Hyderabad: As part of the Musi rejuvenation project and also towards the target of starting daily supply of drinking water to the city, chief minister A Revanth Reddy on Monday will lay the foundation ...
LOS GATOS, Calif. & ROŽŇAVSKÉ BYSTRÉ, Slovakia--(BUSINESS WIRE)--Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today ...
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society of Cardiology Congress 2025 - - Zilebesiran Demonstrated Clinically Meaningful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback